Josh Brumm
2022
In 2022, Josh Brumm earned a total compensation of $4.3M as Former President and Chief Executive Officer at Dyne Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $335,500 |
|---|---|
| Option Awards | $1,661,236 |
| Salary | $610,000 |
| Stock Awards | $1,709,371 |
| Other | $996 |
| Total | $4,317,103 |
Brumm received $1.7M in stock awards, accounting for 40% of the total pay in 2022.
Brumm also received $335.5K in non-equity incentive plan, $1.7M in option awards, $610K in salary and $996 in other compensation.
Rankings
In 2022, Josh Brumm's compensation ranked 777th out of 5,625 executives tracked by ExecPay. In other words, Brumm earned more than 86.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 777 out of 5,625 | 86th |
Division Manufacturing | 351 out of 3,053 | 89th |
Major group Chemicals And Allied Products | 115 out of 1,380 | 92nd |
Industry group Drugs | 102 out of 1,281 | 92nd |
Industry Pharmaceutical Preparations | 75 out of 927 | 92nd |
Source: SEC filing on April 5, 2024.
Brumm's colleagues
We found three more compensation records of executives who worked with Josh Brumm at Dyne Therapeutics in 2022.